Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor
一线去甲基化药物维奈托克联合FLT3抑制剂治疗FLT3突变型急性髓系白血病患者的长期疗效
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.288553
Short, Nicholas J; Loghavi, Sanam; Yilmaz, Musa; Karrar, Omer; Kim, Kunhwa; Dinardo, Courtney D; Kadia, Tapan M; Maroun, Manuel; Borthakur, Gautam; Issa, Ghayas C; Jabbour, Joseph; Oran, Betul; Shpall, Elizabeth J; Popat, Uday; Patel, Keyur P; Routbort, Mark; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval